Be Aware of the Role of Pharmacogenetic Testing for Mental Health Conditions

You'll hear debate about using pharmacogenetic testing to guide treatment for depression, ADHD, and other mental health conditions.

The goal of testing is to identify gene variations that may predict how a patient responds to certain meds.

For example, patients who are ultrarapid CYP2C19 metabolizers may have lower blood levels of citalopram...and poor CYP2D6 metabolizers may have higher blood levels of atomoxetine (Strattera).

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals